Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
about
Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinomaHuman tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaSeverity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinomaPrognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospectsCirculating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinomaPromotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinomaPrognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinomaTGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCCExtending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential.Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability.The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factorAutocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 ExpressionLesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years.Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinomaRecombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionRepeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review.C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activityAdjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceOverexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significancemiR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in miceComparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinomaHigh expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.Prognostic significance of interleukin 17 in cancer: a meta-analysis.The prognostic significance of clinical and pathological features in hepatocellular carcinoma.
P2860
Q24202070-7E95D4BD-B2DD-40DD-AC4F-C2126D740A01Q24309719-00EEF43F-D2A2-4A39-9343-941DCA36949CQ26772324-A0409321-6FF4-4F15-A849-CAF385D15087Q26849546-64B6A03B-03F5-42F8-AFBD-C9C470F9F401Q27013963-80F21428-2E49-4BC1-806C-C58A29E9865BQ27021265-FF3FF714-6E36-4D6C-86CB-65E855D09F4AQ27485911-75DE015C-4D9F-4DE2-9F63-04CD4E0DF14FQ28275597-E7BC3919-F94F-4EC0-9AE0-A63110AC006AQ28917139-360A6224-CD1E-43A1-9232-9788410181E4Q31120411-225339E3-9C53-43B0-AE6A-993F9D6B81DDQ31164960-9BB383C1-AF3E-4425-A313-D3938D023436Q33482513-EC27CD39-550C-4109-A5B2-9C00A631809CQ33591632-BF9A492D-71F7-4B47-A626-7340A9FAD3F2Q33648955-09364234-07BE-46A8-B07D-E58CA4678FCAQ33748658-0D490BE0-6736-4AF2-B97F-D2F46982B026Q33755370-16879569-2B49-489F-91CF-EB653176B438Q33802666-E61967B5-8F06-434D-A43C-DFAF5953581DQ33809381-5E11AF92-45F0-4BDF-9798-9631451C48DEQ33820856-F27591BB-0A47-4DFB-9672-5CC68F60057CQ33827477-010E390B-3732-4897-B485-DAD1A4014F27Q33830807-826D79F2-64BB-490F-9B18-0D6404E8945EQ33838977-4B40E9CC-FF52-4F39-BCC3-214597639377Q33913408-FF37BB4D-C3ED-4A90-A364-08AFEC9708A5Q33937557-0A17F29F-0CDB-452E-8D07-837A43896464Q33948280-2D5168DC-AC50-4F8F-A310-104A1B8D55DCQ33977014-09E14EB5-BFBB-42BA-91AB-D9E0153DCBA0Q33986185-0FC18EA0-A7CC-4E1E-86DB-2689DABE514BQ33995733-EDE97B2A-C99A-4F2F-8D79-E6A56D977C78Q33999174-9EC5B7BC-F089-4E9E-9D4B-C66D086A27E4Q34093919-414EE0A6-75CE-4250-9683-8E1381F7A1C2Q34144126-2082BDAA-7AB0-42AD-B6F3-8FF4E233A519Q34146018-53521F6C-9EC8-4996-A89D-5117B69BD3F3Q34168643-37B34FC4-C02A-4F60-A4A8-AA51C0E4B47DQ34225865-A2088C31-C77D-4402-A133-D88AA8E8091AQ34359096-CD73823A-ED08-4A13-9263-8756FC8C847BQ34364217-5DD880E2-6D0F-4D18-B564-E8B947FFBF02Q34432197-45088C78-0FBA-4897-AA96-D2348176531FQ34482559-45B56E7E-0FCB-4D38-A040-E48E4D2760CFQ34547722-9AEC0066-12B1-4938-889F-2DE686813967Q34582844-95D5C0BF-2B29-4E66-BCAA-9EDEC1E04FAB
P2860
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@ast
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@en
type
label
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@ast
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@en
prefLabel
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@ast
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Risk factors, prevention, and ...... n of hepatocellular carcinoma.
@en
P2093
P2860
P356
10.1097/00000658-200007000-00003
P407
P577
2000-07-01T00:00:00Z